Company intelligence / Profile preview
CYGNOS BioTech
Miami, FL, USAcygnosbiotech.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
CYGNOS BioTech is a South Florida-based biotechnology company founded in 2023 as an outgrowth of Nuovo Biologics. The company operates under a "One Health" paradigm, developing biologic therapeutics that address both animal and human health needs, with an initial focus on the veterinary sector to leverage translational data for human drug development. Their lead programs include PVX, a broad-spectrum antiviral peptide derived from cobra venom toxin, and MMX, an antitumor formulation for canine malignant melanoma which has received FDA Minor Use designation. In addition to its internal pipeline, CYGNOS provides contract research organization (CRO) services specializing in biologics R&D, regulatory support, and veterinary clinical trials.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- PeptidesProteinBiologic
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
CAAT Friends Rescue Network
Beyond the preview
Go deeper on CYGNOS BioTech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CYGNOS BioTech.